LSU AI platform used to create COVID-19 treatment

LSU researchers and drug company Skymount Medical are beginning studies on COVID-19 patients involving a combination of medicines, known as SM-19, that have shown to reduce viral load in initial tests…


Already an INSIDER? Sign in.